Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market 2018, Forecast to 2023
A biomarker is, according to the US National Institutes of Health, “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.”
Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.
Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.
We can discriminate four main types of molecular biomarkers:
• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
• Proteomic biomarkers: Base on the analysis of the protein profiles.
• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).
Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.
Scope of the Report:
This report focuses on the Commercializing Biomarkers in Therapeutic and Diagnostic Applications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of Commercializing Biomarkers in Therapeutic and Diagnostic Applications developed rapidly, with an average growth rate of 8.49%. In 2015, the consumables revenue growth rate was about 8.5%, the services revenue growth rate was nearly 8.6%, and the consumables revenue growth rate was the highest among the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry.
North America is the largest consumer of Commercializing Biomarkers, with the sales market share nearly 42%.
The second place is Europe, following North America with the sales market share of 31%. Japan and China is also the important market, with the total sales marker share of 18.6%.
The worldwide market for Commercializing Biomarkers in Therapeutic and Diagnostic Applications is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 24400 million US$ in 2023, from 17200 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, with sales, revenue, and price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Commercializing Biomarkers in Therapeutic and Diagnostic Applications market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.
Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.
We can discriminate four main types of molecular biomarkers:
• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
• Proteomic biomarkers: Base on the analysis of the protein profiles.
• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).
Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.
Scope of the Report:
This report focuses on the Commercializing Biomarkers in Therapeutic and Diagnostic Applications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of Commercializing Biomarkers in Therapeutic and Diagnostic Applications developed rapidly, with an average growth rate of 8.49%. In 2015, the consumables revenue growth rate was about 8.5%, the services revenue growth rate was nearly 8.6%, and the consumables revenue growth rate was the highest among the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry.
North America is the largest consumer of Commercializing Biomarkers, with the sales market share nearly 42%.
The second place is Europe, following North America with the sales market share of 31%. Japan and China is also the important market, with the total sales marker share of 18.6%.
The worldwide market for Commercializing Biomarkers in Therapeutic and Diagnostic Applications is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 24400 million US$ in 2023, from 17200 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Roche
- Dako (Agilent Technologies)
- Merck
- BD
- Abbott
- Genesys Biolabs (20/20GeneSystems)
- Affymetrix
- Agendia
- ALMAC
- Arrayit
- Biocartic
- BG Medicine
- KEGG EXPRESSION Database
- Thermo Fisher
- BGI
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Consumables
- Services
- Software
- Oncology
- Cardiology
- Neurology
- Other
Chapter 1, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, with sales, revenue, and price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Commercializing Biomarkers in Therapeutic and Diagnostic Applications market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
1.2 Market Analysis by Type
1.2.1 Consumables
1.2.2 Services
1.2.3 Software
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Neurology
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Business Overview
2.1.1.1 Roche Description
2.1.1.2 Roche Headquarter, Main Business and Finance Overview
2.1.2 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.1.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.1.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.2 Dako (Agilent Technologies)
2.2.1 Business Overview
2.2.1.1 Dako (Agilent Technologies) Description
2.2.1.2 Dako (Agilent Technologies) Headquarter, Main Business and Finance Overview
2.2.2 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.2.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.2.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.3 Merck
2.3.1 Business Overview
2.3.1.1 Merck Description
2.3.1.2 Merck Headquarter, Main Business and Finance Overview
2.3.2 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.3.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.3.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.4 BD
2.4.1 Business Overview
2.4.1.1 BD Description
2.4.1.2 BD Headquarter, Main Business and Finance Overview
2.4.2 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.4.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.4.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.5 Abbott
2.5.1 Business Overview
2.5.1.1 Abbott Description
2.5.1.2 Abbott Headquarter, Main Business and Finance Overview
2.5.2 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.5.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.5.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.6 Genesys Biolabs (20/20GeneSystems)
2.6.1 Business Overview
2.6.1.1 Genesys Biolabs (20/20GeneSystems) Description
2.6.1.2 Genesys Biolabs (20/20GeneSystems) Headquarter, Main Business and Finance Overview
2.6.2 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.6.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.6.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.7 Affymetrix
2.7.1 Business Overview
2.7.1.1 Affymetrix Description
2.7.1.2 Affymetrix Headquarter, Main Business and Finance Overview
2.7.2 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.7.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.7.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.8 Agendia
2.8.1 Business Overview
2.8.1.1 Agendia Description
2.8.1.2 Agendia Headquarter, Main Business and Finance Overview
2.8.2 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.8.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.8.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.9 ALMAC
2.9.1 Business Overview
2.9.1.1 ALMAC Description
2.9.1.2 ALMAC Headquarter, Main Business and Finance Overview
2.9.2 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.9.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.9.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.10 Arrayit
2.10.1 Business Overview
2.10.1.1 Arrayit Description
2.10.1.2 Arrayit Headquarter, Main Business and Finance Overview
2.10.2 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.10.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.10.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.11 Biocartic
2.11.1 Business Overview
2.11.2 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.11.3 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BG Medicine
2.12.1 Business Overview
2.12.2 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.12.3 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 KEGG EXPRESSION Database
2.13.1 Business Overview
2.13.2 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.13.3 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Thermo Fisher
2.14.1 Business Overview
2.14.2 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.14.3 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 BGI
2.15.1 Business Overview
2.15.2 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.15.3 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2017
3.4.2 Top 5 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET ANALYSIS BY REGIONS
4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Regions
4.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions (2013-2018)
4.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions (2013-2018)
4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
5.1.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
5.1.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
5.1.3 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
5.1.4 Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
5.1.5 Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
5.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
5.2.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
5.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
5.3.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
5.4 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
5.4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
6 EUROPE COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
6.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
6.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
6.1.3 Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.4 UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.5 France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.6 Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.7 Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
6.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
6.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
7.1.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.4 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.5 Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.6 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
8.1.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
8.1.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
8.1.3 Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
8.1.4 Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
8.1.5 Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
8.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
8.2.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
8.3 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
8.3.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
8.4 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
8.4.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.4 UAE Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.5 Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.7 South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET SEGMENT BY TYPE
10.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Type (2013-2018)
10.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2013-2018)
10.2 Consumables Sales Growth and Price
10.2.1 Global Consumables Sales Growth (2013-2018)
10.2.2 Global Consumables Price (2013-2018)
10.3 Services Sales Growth and Price
10.3.1 Global Services Sales Growth (2013-2018)
10.3.2 Global Services Price (2013-2018)
10.4 Software Sales Growth and Price
10.4.1 Global Software Sales Growth (2013-2018)
10.4.2 Global Software Price (2013-2018)
11 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET SEGMENT BY APPLICATION
11.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Cardiology Sales Growth (2013-2018)
11.4 Neurology Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET FORECAST (2018-2023)
12.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2018-2023)
12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Regions (2018-2023)
12.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.4 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.5 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Type (2018-2023)
12.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Type (2018-2023)
12.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Type (2018-2023)
12.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Application (2018-2023)
12.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Application (2018-2023)
12.4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
1
1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
1.2 Market Analysis by Type
1.2.1 Consumables
1.2.2 Services
1.2.3 Software
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Neurology
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Business Overview
2.1.1.1 Roche Description
2.1.1.2 Roche Headquarter, Main Business and Finance Overview
2.1.2 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.1.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.1.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.2 Dako (Agilent Technologies)
2.2.1 Business Overview
2.2.1.1 Dako (Agilent Technologies) Description
2.2.1.2 Dako (Agilent Technologies) Headquarter, Main Business and Finance Overview
2.2.2 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.2.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.2.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.3 Merck
2.3.1 Business Overview
2.3.1.1 Merck Description
2.3.1.2 Merck Headquarter, Main Business and Finance Overview
2.3.2 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.3.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.3.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.4 BD
2.4.1 Business Overview
2.4.1.1 BD Description
2.4.1.2 BD Headquarter, Main Business and Finance Overview
2.4.2 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.4.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.4.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.5 Abbott
2.5.1 Business Overview
2.5.1.1 Abbott Description
2.5.1.2 Abbott Headquarter, Main Business and Finance Overview
2.5.2 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.5.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.5.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.6 Genesys Biolabs (20/20GeneSystems)
2.6.1 Business Overview
2.6.1.1 Genesys Biolabs (20/20GeneSystems) Description
2.6.1.2 Genesys Biolabs (20/20GeneSystems) Headquarter, Main Business and Finance Overview
2.6.2 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.6.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.6.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.7 Affymetrix
2.7.1 Business Overview
2.7.1.1 Affymetrix Description
2.7.1.2 Affymetrix Headquarter, Main Business and Finance Overview
2.7.2 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.7.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.7.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.8 Agendia
2.8.1 Business Overview
2.8.1.1 Agendia Description
2.8.1.2 Agendia Headquarter, Main Business and Finance Overview
2.8.2 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.8.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.8.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.9 ALMAC
2.9.1 Business Overview
2.9.1.1 ALMAC Description
2.9.1.2 ALMAC Headquarter, Main Business and Finance Overview
2.9.2 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.9.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.9.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.10 Arrayit
2.10.1 Business Overview
2.10.1.1 Arrayit Description
2.10.1.2 Arrayit Headquarter, Main Business and Finance Overview
2.10.2 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.10.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
2.10.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Information
2.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share in 2017
2.11 Biocartic
2.11.1 Business Overview
2.11.2 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.11.3 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BG Medicine
2.12.1 Business Overview
2.12.2 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.12.3 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 KEGG EXPRESSION Database
2.13.1 Business Overview
2.13.2 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.13.3 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Thermo Fisher
2.14.1 Business Overview
2.14.2 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.14.3 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 BGI
2.15.1 Business Overview
2.15.2 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Introduction
2.15.3 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2017
3.4.2 Top 5 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET ANALYSIS BY REGIONS
4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Regions
4.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions (2013-2018)
4.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions (2013-2018)
4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
5.1.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
5.1.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
5.1.3 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
5.1.4 Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
5.1.5 Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
5.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
5.2.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
5.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
5.3.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
5.4 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
5.4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
6 EUROPE COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
6.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
6.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
6.1.3 Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.4 UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.5 France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.6 Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.1.7 Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
6.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
6.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
6.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
7.1.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.4 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.5 Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.6 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
8.1.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
8.1.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
8.1.3 Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
8.1.4 Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
8.1.5 Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
8.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
8.2.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
8.3 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
8.3.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
8.4 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
8.4.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.4 UAE Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.5 Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.1.7 South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET SEGMENT BY TYPE
10.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Type (2013-2018)
10.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2013-2018)
10.2 Consumables Sales Growth and Price
10.2.1 Global Consumables Sales Growth (2013-2018)
10.2.2 Global Consumables Price (2013-2018)
10.3 Services Sales Growth and Price
10.3.1 Global Services Sales Growth (2013-2018)
10.3.2 Global Services Price (2013-2018)
10.4 Software Sales Growth and Price
10.4.1 Global Software Sales Growth (2013-2018)
10.4.2 Global Software Price (2013-2018)
11 GLOBAL COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET SEGMENT BY APPLICATION
11.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Cardiology Sales Growth (2013-2018)
11.4 Neurology Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MARKET FORECAST (2018-2023)
12.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2018-2023)
12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Regions (2018-2023)
12.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.4 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.2.5 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
12.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Type (2018-2023)
12.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Type (2018-2023)
12.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Type (2018-2023)
12.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Application (2018-2023)
12.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Application (2018-2023)
12.4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
1
LIST OF TABLES AND FIGURES
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture
Table Product Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2017
Figure Consumables Picture
Table Major Manufacturers of Consumables
Figure Services Picture
Table Major Manufacturers of Services
Figure Software Picture
Table Major Manufacturers of Software
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Cardiology Picture
Figure Neurology Picture
Figure Other Picture
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Dako (Agilent Technologies) Headquarter, Established, Main Business and Finance Overview (2017)
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table BD Headquarter, Established, Main Business and Finance Overview (2017)
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Abbott Headquarter, Established, Main Business and Finance Overview (2017)
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Genesys Biolabs (20/20GeneSystems) Headquarter, Established, Main Business and Finance Overview (2017)
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Affymetrix Headquarter, Established, Main Business and Finance Overview (2017)
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Agendia Headquarter, Established, Main Business and Finance Overview (2017)
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table ALMAC Headquarter, Established, Main Business and Finance Overview (2017)
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Arrayit Headquarter, Established, Main Business and Finance Overview (2017)
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Biocartic
Table Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table BG Medicine
Table BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table KEGG EXPRESSION Database
Table KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Thermo Fisher
Table Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table BGI
Table BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Manufacturer (2016-2017)
Figure Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2017
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions (2013-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2013
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2017
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2013
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2017
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2013
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2016
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries 2017
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries 2017
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2017
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2017
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2013
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure UAE Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Figure Global Consumables Sales Growth (2013-2018)
Figure Global Consumables Price (2013-2018)
Figure Global Services Sales Growth (2013-2018)
Figure Global Services Price (2013-2018)
Figure Global Software Sales Growth (2013-2018)
Figure Global Software Price (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Cardiology Sales Growth (2013-2018)
Figure Global Neurology Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2018-2023)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Regions (2018-2023)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Regions (2018-2023)
Figure North America Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
Figure Europe Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
Figure Asia-Pacific Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
Figure South America Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (20
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture
Table Product Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2017
Figure Consumables Picture
Table Major Manufacturers of Consumables
Figure Services Picture
Table Major Manufacturers of Services
Figure Software Picture
Table Major Manufacturers of Software
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Cardiology Picture
Figure Neurology Picture
Figure Other Picture
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2013-2023)
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Dako (Agilent Technologies) Headquarter, Established, Main Business and Finance Overview (2017)
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table BD Headquarter, Established, Main Business and Finance Overview (2017)
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Abbott Headquarter, Established, Main Business and Finance Overview (2017)
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Genesys Biolabs (20/20GeneSystems) Headquarter, Established, Main Business and Finance Overview (2017)
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Affymetrix Headquarter, Established, Main Business and Finance Overview (2017)
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Agendia Headquarter, Established, Main Business and Finance Overview (2017)
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table ALMAC Headquarter, Established, Main Business and Finance Overview (2017)
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Arrayit Headquarter, Established, Main Business and Finance Overview (2017)
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Production Bases, Sales Regions and Major Competitors
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share in 2017
Figure Global Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share in 2017
Table Biocartic
Table Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table BG Medicine
Table BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table KEGG EXPRESSION Database
Table KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Thermo Fisher
Table Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table BGI
Table BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Manufacturer (2016-2017)
Figure Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2017
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions (2013-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2013
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2017
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2013
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2017
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2013-2018)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2013
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2016
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries 2017
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries 2017
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2017
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2013-2018)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2017
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2013
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure UAE Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Application (2013-2018)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2013-2018)
Figure Global Consumables Sales Growth (2013-2018)
Figure Global Consumables Price (2013-2018)
Figure Global Services Sales Growth (2013-2018)
Figure Global Services Price (2013-2018)
Figure Global Software Sales Growth (2013-2018)
Figure Global Software Price (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2013-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Cardiology Sales Growth (2013-2018)
Figure Global Neurology Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2018-2023)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Regions (2018-2023)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Regions (2018-2023)
Figure North America Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
Figure Europe Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
Figure Asia-Pacific Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2018-2023)
Figure South America Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (20
